Vanguard Mega Cap Value ETF
MGV - ETF AI Analysis
Top Page
Vanguard Mega Cap Value ETF (MGV)
MGV, the Vanguard Mega Cap Value ETF, earns a solid overall rating thanks to several high-quality, diversified blue-chip holdings like Johnson & Johnson, Walmart, Micron, and Cisco, which show strong financial performance, positive earnings calls, and strategic positioning in areas like AI and e-commerce. The fund’s score is held back somewhat by names such as AbbVie and Costco, where high valuations, leverage, or bearish technical trends introduce more uncertainty. A key risk factor is its meaningful exposure to large financial and energy companies like JPMorgan, Bank of America, and Exxon Mobil, which can make the ETF more sensitive to interest rate changes and commodity market swings.
MGV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 14.25B
- Region
- North America
- Expense Ratio
- 0.05%
- Beta
- 0.64
- Issuer
- Vanguard
- Inception Date
- Dec 17, 2007
- Dividend Yield
- 1.80%
- Asset Class
- Equity
- Index Tracked
- Morningstar US Mega Cap Value TR USD
MGV Summary
Vanguard Mega Cap Value ETF (MGV) is a fund that follows the Morningstar US Mega Cap Value index, focusing on very large U.S. companies that are considered relatively cheap compared with their business strength. It owns well-known names like JPMorgan Chase, Berkshire Hathaway, Exxon Mobil, Johnson & Johnson, Walmart, and Costco, across sectors such as financials, health care, and energy. Investors might choose MGV for broad diversification into big, established companies with potential for steady growth and income. A key risk is that value stocks and the overall stock market can go up and down, so your investment can lose money, especially in market downturns.
How much will it cost me?
This ETF has an expense ratio of 0.05%, which means you’ll pay about $0.50 per year for every $1,000 invested. That’s lower than the average ETF because it’s a passively managed fund that tracks an index, keeping costs down.
What would affect this ETF?
MGV could benefit if the U.S. economy stays resilient, interest rates stabilize or fall, and value stocks in sectors like financials, health care, and energy come back into favor, helping major holdings such as JPMorgan, Johnson & Johnson, and Exxon Mobil. On the downside, a U.S. recession, renewed stress on banks, tighter regulations on large financial or energy companies, or a shift back toward fast-growing tech stocks over value names could weigh on this ETF’s future performance.
MGV Top 10 Holdings
MGV leans heavily on U.S. mega-cap value names, with financials, health care, and energy doing much of the heavy lifting. Berkshire Hathaway and JPMorgan provide a steady backbone, while Exxon and Chevron have been rising on the back of strong energy markets, giving the fund a powerful cyclical tilt. Johnson & Johnson and AbbVie add a defensive health care layer that’s been quietly climbing. The main drag comes from Micron, where performance has been mixed lately, reminding investors that even value-tilted tech can lose steam.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MU | Micron | 5.91% | $801.52M | $820.41B | 236.49% | 79Outperform |
 JPM | JPMorgan Chase | 4.32% | $585.96M | $908.40B | 8.80% | 72Outperform |
 BRK.B | Berkshire Hathaway B | 3.46% | $469.38M | $1.25T | 18.34% | 66Neutral |
 XOM | Exxon Mobil | 3.32% | $449.43M | $670.91B | 39.18% | 74Outperform |
 JNJ | Johnson & Johnson | 3.14% | $425.10M | $675.92B | 44.67% | 78Outperform |
 ABBV | AbbVie | 2.27% | $308.01M | $519.48B | 31.00% | 66Neutral |
 WMT | Walmart | 2.24% | $303.07M | $996.08B | 21.49% | 78Outperform |
 COST | Costco | 1.99% | $269.00M | $472.44B | 19.01% | 72Outperform |
 CVX | Chevron | 1.88% | $255.40M | $415.14B | 36.51% | 71Outperform |
 CSCO | Cisco Systems | 1.88% | $254.39M | $386.41B | 40.51% | 77Outperform |
MGV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MGV, the sentiment is Positive. The current price of 170.75 is above the 20-day moving average (MA) of 167.74, above the 50-day MA of 165.45, and above the 200-day MA of 157.62, indicating a bullish trend. The MACD of 1.10 indicates Negative momentum. The RSI at 60.91 is Neutral, neither overbought nor oversold. The STOCH value of 66.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MGV.
MGV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MGV | $170.75 | $183.00(7.17% Upside) | $14.25B | 0.05% | 73Outperform |
 VTV | $230.04 | $267.01(16.07% Upside) | $195.75B | 0.03% | 73Outperform |
 IWD | $263.81 | $296.30(12.31% Upside) | $84.71B | 0.18% | 72Outperform |
 IVE | $242.73 | $270.29(11.35% Upside) | $51.40B | 0.18% | 72Outperform |
 SPYV | $65.01 | $72.32(11.25% Upside) | $38.65B | 0.04% | 72Outperform |
 VONV | $115.70 | $131.53(13.68% Upside) | $23.59B | 0.06% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MGV | Vanguard Mega Cap Value ETF | 170.75 | 34.63 | 25.44% | |
| VTV | Vanguard Value ETF | 230.04 | 46.26 | 25.17% | |
| IWD | iShares Russell 1000 Value ETF | 263.81 | 61.48 | 30.39% | |
| IVE | iShares S&P 500 Value ETF | 242.73 | 36.07 | 17.45% | |
| SPYV | SPDR Portfolio S&P 500 Value ETF | 65.01 | 9.72 | 17.59% | |
| VONV | Vanguard Russell 1000 Value ETF | 115.70 | 27.07 | 30.54% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.